MedTrace Logo

High Intensity Training to Improve Diaphragm Functioning in Persons With Chronic Nonspecific Low Back Pain

NCT05384457 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-10-06

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate 1) the effects of high intensity training (HIT) compared to moderate intensity training (MIT) on diaphragm muscle strength, -endurance, -fatigue and -activation, 2) to which extent these changes in diaphragm functioning are related to changes in cardiorespiratory fitness, postural control, pain and disability after HIT versus MIT, 3) to which extent depressive mood and anxiety moderate the effects of HIT on diaphragm functioning in persons with chronic nonspecific low back pain (CNSLBP). The investigators hypothize that HIT improves diaphragm functioning more compared to MIT in persons with CNSLBP.

Conditions

Interventions

OTHER

High intensity training

Participants will follow an exercise therapy program consisting of cardiorespiratory training, limb strength training and core muscle training.

OTHER

Moderate intensity training

Participants will follow an exercise therapy program consisting of cardiorespiratory training, limb strength training and core muscle training.

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • Maastricht University

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Annick Timmermans · REVAL-Rehabilitation Research Center, Hasselt University, Diepenbeek, Belgium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-22
Primary Completion
2025-06-01
Completion
2025-11-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05384457 on ClinicalTrials.gov